Enovis Shares Outstanding 2010-2023 | ENOV
Enovis shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Enovis Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 54 |
| 2022 | 54 |
| 2021 | 51 |
| 2020 | 46 |
| 2019 | 46 |
| 2018 | 40 |
| 2017 | 41 |
| 2016 | 41 |
| 2015 | 42 |
| 2014 | 41 |
| 2013 | 33 |
| 2012 | 30 |
| 2011 | 15 |
| 2010 | 15 |
| 2009 | 14 |
| Enovis Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-12-31 | 54 |
| 2023-09-30 | 55 |
| 2023-06-30 | 55 |
| 2023-03-31 | 54 |
| 2022-12-31 | 54 |
| 2022-09-30 | 54 |
| 2022-06-30 | 55 |
| 2022-03-31 | 54 |
| 2021-12-31 | 51 |
| 2021-09-30 | 53 |
| 2021-06-30 | 51 |
| 2021-03-31 | 47 |
| 2020-12-31 | 46 |
| 2020-09-30 | 46 |
| 2020-06-30 | 46 |
| 2020-03-31 | 47 |
| 2019-12-31 | 46 |
| 2019-09-30 | 46 |
| 2019-06-30 | 46 |
| 2019-03-31 | 45 |
| 2018-12-31 | 40 |
| 2018-09-30 | 39 |
| 2018-06-30 | 41 |
| 2018-03-31 | 41 |
| 2017-12-31 | 41 |
| 2017-09-30 | 41 |
| 2017-06-30 | 41 |
| 2017-03-31 | 41 |
| 2016-12-31 | 41 |
| 2016-09-30 | 41 |
| 2016-06-30 | 41 |
| 2016-03-31 | 41 |
| 2015-12-31 | 42 |
| 2015-09-30 | 42 |
| 2015-06-30 | 42 |
| 2015-03-31 | 42 |
| 2014-12-31 | 41 |
| 2014-09-30 | 42 |
| 2014-06-30 | 42 |
| 2014-03-31 | 38 |
| 2013-12-31 | 33 |
| 2013-09-30 | 38 |
| 2013-06-30 | 37 |
| 2013-03-31 | 32 |
| 2012-12-31 | 30 |
| 2012-09-30 | 32 |
| 2012-06-30 | 32 |
| 2012-03-31 | 27 |
| 2011-12-31 | 15 |
| 2011-09-30 | 15 |
| 2011-06-30 | 15 |
| 2011-03-31 | 15 |
| 2010-12-31 | 15 |
| 2010-09-30 | 15 |
| 2010-06-30 | 15 |
| 2010-03-31 | 14 |
| 2009-12-31 | 14 |
| 2009-09-30 | 14 |
| 2009-06-30 | 14 |
| 2009-03-31 | 14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.030B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
| Inspire Medical Systems (INSP) | United States | $7.194B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.483B | 0.00 |
| Axonics (AXNX) | United States | $3.401B | 0.00 |
| 10x Genomics (TXG) | United States | $3.288B | 0.00 |
| Azenta (AZTA) | United States | $2.910B | 237.18 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.678B | 0.00 |
| Privia Health (PRVA) | United States | $2.167B | 96.11 |
| Schrodinger (SDGR) | United States | $1.733B | 0.00 |
| Omnicell (OMCL) | United States | $1.279B | 31.30 |
| Phreesia (PHR) | United States | $1.162B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.762B | 0.00 |
| Standard BioTools (LAB) | United States | $0.708B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.153B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
| Augmedix (AUGX) | United States | $0.139B | 0.00 |
| Outset Medical (OM) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.03 |
| 111 (YI) | China | $0.086B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
| Movano (MOVE) | United States | $0.047B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |